// App-Quantinova.ai

446 : Ex Vivo T Cell Depleted HLA-Matched PBSCT with Post-Transplant Activated Donor-Derived NK Cell Infusions for High-Risk Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Nirali N Shah

Principal Investigators

  • Bonnie Yates

  • Cindy Delbrook

  • Shakuntala Rampertaap

  • Kimberly Lemberg

  • Marianna Sabatino

  • David F. Stroncek

  • Hua Zhang

  • Terry J Fry

  • Crystal L Mackall

  • Daniel W Lee

  • Thomas Fleisher

Medical Centers

  • National Institute of Health, Bethesda, MD

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Natural Killer cells

  • Breakpoint Cluster Region

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 34

  • Cluster of Differentiation 56

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Filgrastim

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved